{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T11:46:03Z","timestamp":1784720763403,"version":"3.55.0"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,5,21]],"date-time":"2019-05-21T00:00:00Z","timestamp":1558396800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100005646","name":"Actelion Pharmaceuticals","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005646","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Genetics and Metabolism Reports"],"published-print":{"date-parts":[[2019,9]]},"DOI":"10.1016\/j.ymgmr.2019.100477","type":"journal-article","created":{"date-parts":[[2019,6,3]],"date-time":"2019-06-03T21:03:00Z","timestamp":1559595780000},"page":"100477","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Prevalence of antibodies to ganglioside and Hep 2 in Gaucher, Niemann \u2013 Pick type C and Sanfilippo diseases"],"prefix":"10.1016","volume":"20","author":[{"given":"Evangelia","family":"Dimitriou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evangelia","family":"Paschali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Kanariou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen","family":"Michelakakis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymgmr.2019.100477_bb0005","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1038\/nrneurol.2013.163","article-title":"Lysosomal storage diseases the horizon expands","volume":"9","author":"Boustany","year":"2013","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.ymgmr.2019.100477_bb0010","first-page":"59","article-title":"Lysosomal storage diseases: old diseases, present and future challenges","volume":"1","author":"Klein","year":"2013","journal-title":"Pediatr Endocrinol Rev Suppl"},{"issue":"5","key":"10.1016\/j.ymgmr.2019.100477_bb0015","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1083\/jcb.201208152","article-title":"Lysosomal storage disorders. The cellular impact of lysosomal dysfunction","volume":"199","author":"Platt","year":"2012","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.ymgmr.2019.100477_bb0020","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1038\/nrm3565","article-title":"Signals from the lysosome a control center for cellular clearance and energy metabolism","volume":"14","author":"Settembre","year":"2013","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.ymgmr.2019.100477_bb0025","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/s00401-007-0296-4","article-title":"Immune system irregularities in lysosomal storage diseases","volume":"115","author":"Castaneda","year":"2008","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.ymgmr.2019.100477_bb0030","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1002\/jnr.21912","article-title":"Innate and adaptive immune activation in the brain of MPS III B mouse models","volume":"87","author":"Di Rosario","year":"2009","journal-title":"J. Neurosci. Res."},{"issue":"3","key":"10.1016\/j.ymgmr.2019.100477_bb0035","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/S0925-4439(96)00056-7","article-title":"Plasma tumor necrosis factor (TNF-a) levels in Gaucher disease","volume":"1317","author":"Michelakakis","year":"1996","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.ymgmr.2019.100477_bb0040","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1056\/NEJMoa1508808","article-title":"Clonal immunoglobulin against Lysolipids in the origin of myeloma","volume":"374","author":"Nair","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ymgmr.2019.100477_bb0045","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1615\/CritRevOncog.2013004503","article-title":"Immunological cells and functions in Gaucher disease","volume":"18","author":"Pandey","year":"2013","journal-title":"Crit. Rev. Oncol."},{"key":"10.1016\/j.ymgmr.2019.100477_bb0050","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1038\/nature21368","article-title":"Complement drives glucosylceramide accumulation and tissue inflammation in Gaucher disease","volume":"543","author":"Pandey","year":"2017","journal-title":"Nature"},{"issue":"Suppl. 1","key":"10.1016\/j.ymgmr.2019.100477_bb0055","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1111\/jnc.13138","article-title":"Immune dysfunction in Niemann-pick disease type C","volume":"136","author":"Platt","year":"2016","journal-title":"J. Neurochem."},{"key":"10.1016\/j.ymgmr.2019.100477_bb0060","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.imlet.2017.07.004","article-title":"Overview of immune abnormalities in lysosomal storage disorders","volume":"188","author":"Rigante","year":"2017","journal-title":"Immunol. Lett."},{"key":"10.1016\/j.ymgmr.2019.100477_bb0065","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1172\/JCI200419639","article-title":"Possible role of autoantibodies in the pathophysiology of GM2-gangliosidoses","volume":"113","author":"Yamaguchi","year":"2004","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ymgmr.2019.100477_bb0070","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1111\/bjh.12335","article-title":"Malignanscies and monoclonal gammopathy in Gaucher disease; a systemic review of the literature","volume":"161","author":"Arends","year":"2013","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.ymgmr.2019.100477_bb0075","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1007\/BF01541326","article-title":"Natural autoantibodies in sera of patients with Gaucher disease","volume":"15","author":"Shoenfeld","year":"1995","journal-title":"J. Clin. Immunol."},{"key":"10.1016\/j.ymgmr.2019.100477_bb0080","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.jbspin.2016.12.002","article-title":"Prevalence of autoantibodies in the course of Gaucher disease type I a multicenter study comparing Gaucher disease patient to healthy subjects","volume":"85","author":"Serratrice","year":"2018","journal-title":"Joint Bone Spine"},{"key":"10.1016\/j.ymgmr.2019.100477_bb0085","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/1750-1172-5-16","article-title":"Niemann pick type C","volume":"5","author":"Vanier","year":"2010","journal-title":"Orphanet. J. Rare. Dis."},{"key":"10.1016\/j.ymgmr.2019.100477_bb0090","doi-asserted-by":"crossref","first-page":"161","DOI":"10.14348\/molcells.2014.2347","article-title":"Inhibition of GM3 synthase attenuates neuropathology of Niemann pick disease type C by affecting sphingolipid metabolism","volume":"37","author":"Lee","year":"2014","journal-title":"Mol. Cell"},{"key":"10.1016\/j.ymgmr.2019.100477_bb0095","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.jneuroim.2008.06.033","article-title":"Glycosphingolipid depletion in PC12 cells using immunosugars protects neuronal membranes from antiganglioside antibody mediated injury","volume":"203","author":"Townson","year":"2008","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.ymgmr.2019.100477_bb0100","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1016\/S0960-9822(01)00396-7","article-title":"Critical role for glycosphingolipids in Niemann-pick disease type C","volume":"11","author":"Zervas","year":"2001","journal-title":"Curr. Biol."},{"key":"10.1016\/j.ymgmr.2019.100477_bb0105","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1186\/s13023-015-0284-z","article-title":"NPC registry investigators. Stable or improved neurological manifestations during miglustat therapy in patients from the international disease registry for Niemann-pick disease type C: an observational cohort study","volume":"10","author":"Paterson","year":"2015","journal-title":"Orphanet. J. Rare Dis"},{"key":"10.1016\/j.ymgmr.2019.100477_bb0110","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1007\/8904_2016_41","article-title":"The sperctrum of Niemann \u2013 pick type C disease in Greece","volume":"36","author":"Mavridou","year":"2017","journal-title":"JIMD Reports"},{"key":"10.1016\/j.ymgmr.2019.100477_bb0115","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1186\/s12881-017-0409-4","article-title":"Novel NPC1 mutations with different segregation in two related Greek patients with Niemman pick type C disease: molecular study in the extended pedigree and clinical correlations","volume":"18","author":"Bountouvi","year":"2017","journal-title":"BMC Med. Genet."},{"issue":"15","key":"10.1016\/j.ymgmr.2019.100477_bb0120","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.semcdb.2004.03.002","article-title":"Secondary increases in ganglioside expression in lysosomal disorders","volume":"2004","author":"Wakley","year":"2004","journal-title":"Semin. Cell Dev."},{"key":"10.1016\/j.ymgmr.2019.100477_bb0125","doi-asserted-by":"crossref","first-page":"2","DOI":"10.3390\/antib5010002","article-title":"Autoantibodies in SLE: specificities, isotypes and receptors","volume":"5","author":"Dema","year":"2016","journal-title":"Antibodies"},{"key":"10.1016\/j.ymgmr.2019.100477_bb0130","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1093\/glycob\/cwl052","article-title":"Gangliosides as components of lipid membrane domains","volume":"17","author":"Sonnino","year":"2007","journal-title":"Glycobiology"},{"key":"10.1016\/j.ymgmr.2019.100477_bb0135","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1016\/j.febslet.2009.10.011","article-title":"Brain gangliosides in axon-myelin stability and axon regeneration","volume":"584","author":"Schnaar","year":"2010","journal-title":"FEBS Lett."},{"key":"10.1016\/j.ymgmr.2019.100477_bb0140","doi-asserted-by":"crossref","first-page":"5440","DOI":"10.1194\/jlr.R800028-JLR200","article-title":"The role of glycosphingolipid metabolism in the developing brain","volume":"50","author":"Yu","year":"2009","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.ymgmr.2019.100477_bb0145","doi-asserted-by":"crossref","first-page":"3049","DOI":"10.4049\/jimmunol.155.6.3049","article-title":"Analysis of anti-GM antibodies cloned from motor neuropathy patients demonstrates diverse variable region gene usage with extensive somatic mutation","volume":"155","author":"Paterson","year":"1995","journal-title":"J. Immunol."},{"key":"10.1016\/j.ymgmr.2019.100477_bb0150","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1172\/JCI118529","article-title":"A somatically mutated human anti-ganglioside antibody that induces experimental neuropathy in mice is encoded by the variable region heavy chain gene","volume":"97","author":"Willison","year":"1996","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ymgmr.2019.100477_bb0155","first-page":"516","article-title":"Anti-glycolipid antibodies in the diagnosis of autoimmune neuropathies","volume":"158","author":"Willison","year":"2002","journal-title":"Rev. Neurol. (Paris)"},{"key":"10.1016\/j.ymgmr.2019.100477_bb0160","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/S1474-4422(08)70215-1","article-title":"Clinical features, pathogenesis and treatment of Guillain \u2013 Barre syndrome","volume":"7","author":"Van Doorn","year":"2008","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.ymgmr.2019.100477_bb0165","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0022-510X(99)00180-X","article-title":"Acute motor axonal neuropathy and acute motor \u2013 sensory axonal neuropathy share a common immunological profile","volume":"168","author":"Yuki","year":"1999","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.ymgmr.2019.100477_bb0170","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1136\/jnnp.2010.222836","article-title":"Ataxic Guillain \u2013 Barre syndrome and acute sensory ataxia neuropathy form a continuous spectrum","volume":"82","author":"Ito","year":"2011","journal-title":"J. Neurol. Neurosurg. Psychiatry"}],"container-title":["Molecular Genetics and Metabolism Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2214426919300291?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2214426919300291?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T12:51:27Z","timestamp":1762001487000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2214426919300291"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9]]},"references-count":34,"alternative-id":["S2214426919300291"],"URL":"https:\/\/doi.org\/10.1016\/j.ymgmr.2019.100477","relation":{},"ISSN":["2214-4269"],"issn-type":[{"value":"2214-4269","type":"print"}],"subject":[],"published":{"date-parts":[[2019,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prevalence of antibodies to ganglioside and Hep 2 in Gaucher, Niemann \u2013 Pick type C and Sanfilippo diseases","name":"articletitle","label":"Article Title"},{"value":"Molecular Genetics and Metabolism Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymgmr.2019.100477","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"100477"}}